European Biotech Acquisition Corp. Units
EBACU
EBACU was delisted on the 2nd of March, 2023.
26 hedge funds and large institutions have $23.2M invested in European Biotech Acquisition Corp. Units in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 7 closing their positions.
13% less funds holding
Funds holding: 30 → 26 (-4)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
27% less capital invested
Capital invested by funds: $31.6M → $23.2M (-$8.37M)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$1.49M |
| 2 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$107K |
| 3 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$99.1K |
| 4 |
SMA
Sage Mountain Advisors
Atlanta,
Georgia
|
+$18.4K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$9.92K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$4.62M |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$1.49M |
| 3 |
AMH
Apollo Management Holdings
New York
|
-$992K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$888K |
| 5 |
KSCM
King Street Capital Management
New York
|
-$496K |
EBACU Hedge Fund Activity: Q4 2021 in Review
26 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Units (EBACU) for Q4 2021, worth a combined $23.2M — down 27% from $31.6M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of EBACU and 3 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 5 added.
The largest buyer was Picton Mahoney Asset Management, adding an estimated $1.49M. The largest seller was Periscope Capital, exiting entirely with an estimated $4.62M sold.
- 26 institutional investors held European Biotech Acquisition Corp. Units (EBACU) as of Q4 2021, down from 30 in Q3 2021.
- Funds reported $23.2M of European Biotech Acquisition Corp. Units stock for Q4 2021, down 27% quarter-over-quarter.
- 3 funds opened new European Biotech Acquisition Corp. Units positions in Q4 2021 and 7 closed out, a net change of -4 holders.
- The largest European Biotech Acquisition Corp. Units buyer in Q4 2021 was Picton Mahoney Asset Management, an estimated $1.49M added.
- The largest European Biotech Acquisition Corp. Units seller in Q4 2021 was Periscope Capital, an estimated $4.62M sold.
Based on aggregated 13F filings for Q4 2021.